Development of a novel imaging agent using peptide-coated gold nanoparticles toward brain glioma stem cell marker CD133

Acta Biomaterialia

Volumn 47, Issue , 2017, Pages 182-192

  Cho, Jun Haeng ^a   Kim, A R ^a   Kim, Sang Heon ^a   Lee, Su Jae ^a   Chung, Hoeil ^a   Yoon, Moon Young ^a  

^a Hanyang University   (South Korea)

Author keywords

Cancer stem cells; CD133; Gold nanoparticles; Peptide; Phage display

Indexed keywords

BIOCOMPATIBILITY; CYTOLOGY; DIAGNOSIS; DISEASES; EFFICIENCY; FIBER OPTIC SENSORS; METAL NANOPARTICLES; PEPTIDES; QUENCHING; STEM CELLS; TARGETED DRUG DELIVERY;

CANCER STEM CELLS; CD133; CELL MARKERS; CELL-BE; CELL/B.E; CELL/BE; GLIOBLASTOMAS; IMAGING AGENT; PHAGE-DISPLAY; STEM-CELL;

GOLD NANOPARTICLES;

CBP 4 PROTEIN; CD133 ANTIGEN; GOLD NANOPARTICLE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; GLUTATHIONE; GOLD; MACROGOL DERIVATIVE; METAL NANOPARTICLE; PEPTIDE; TUMOR MARKER;

ARTICLE; BINDING AFFINITY; BIOCOMPATIBILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSOL; ENDOCYTOSIS; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INTERNALIZATION; MOLECULAR CLONING; PHAGE DISPLAY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PURIFICATION; STIMULUS RESPONSE; TUMOR DIAGNOSIS; BRAIN NEOPLASMS; CANCER STEM CELL; CELL DEATH; CELL SURFACE DISPLAY; CHEMISTRY; DIAGNOSTIC IMAGING; DRUG EFFECTS; FLUORESCENCE; GLIOMA; HEK293 CELL LINE; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

AC133 ANTIGEN; BIOMARKERS, TUMOR; BRAIN NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; CELL SURFACE DISPLAY TECHNIQUES; CLONING, MOLECULAR; DIAGNOSTIC IMAGING; ENDOCYTOSIS; FLUORESCENCE; GLIOMA; GLUTATHIONE; GOLD; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; METAL NANOPARTICLES; NEOPLASTIC STEM CELLS; PEPTIDES; POLYETHYLENE GLYCOLS;

EID: 84995513611     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2016.10.009     Document Type: Article

References (52)

1. [1] Omuro, A., DeAngelis, L.M., Glioblastoma and other malignant gliomas: a clinical review. JAMA 310 (2013), 1842–1850.
2. [2] Costa, P.M., Cardoso, A.L., Nobrega, C., Pereira de Almeida, L.F., Bruce, J.N., Canoll, P., Pedroso de Lima, M.C., MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma. Hum. Mol. Genet. 22 (2013), 904–918.
3. [3] Formenti, S.C., Demaria, S., Combining radiotherapy and cancer immunotherapy: a paradigm shift. J. Natl. Cancer Inst. 105 (2013), 256–265.
4. [4] Dungey, F.A., Caldecott, K.W., Chalmers, A.J., Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90. Mol. Cancer Ther. 8 (2009), 2243–2254.
5. [5] Tirino, V., Desiderio, V., Paino, F., De Rosa, A., Papaccio, F., La Noce, M., La Noce, M., Laino, L., De Francesco, F., Papaccio, G., Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. FASEB J. 27 (2013), 13–24.
6. [6] Chen, K., Huang, Y.H., Chen, J.L., Understanding and targeting cancer stem cells: therapeutic implications and challenges. Acta Pharmacol. Sin. 34 (2013), 732–740.
7. [7] Hermann, P.C., Bhaskar, S., Cioffi, M., Heeschen, C., Cancer stem cells in solid tumors. Semin. Cancer Biol. 20 (2010), 77–84.
8. [8] Singh, S.K., Hawkins, C., Clarke, I.D., Squire, J.A., Bayani, J., Hide, T., Henkelman, R.M., Cusimano, M.D., Dirks, P.B., Identification of human brain tumour initiating cells. Nature 432 (2004), 396–401.
9. [9] Brescia, P., Ortensi, B., Fornasari, L., Levi, D., Broggi, G., Pelicci, G., CD133 is essential for glioblastoma stem cell maintenance. Stem Cells 31 (2013), 857–869.
10. [10] Kim, R.K., Suh, Y., Hwang, E., Yoo, K.C., Choi, K.S., An, S., Hwang, S.G., Kim, I.G., Kim, M., Lee, H.J., Lee, S.J., PKCdelta maintains phenotypes of tumor initiating cells through cytokine-mediated autocrine loop with positive feedback. Oncogene, 2015.
11. [11] Pande, J., Szewczyk, M.M., Grover, A.K., Phage display: concept, innovations, applications and future. Biotechnol. Adv. 28 (2010), 849–858.
12. [12] Wang, Y.A., Yu, X., Overman, S., Tsuboi, M., Thomas, G.J. Jr., Egelman, E.H., The structure of a filamentous bacteriophage. J. Mol. Biol. 361 (2006), 209–215.
13. [13] Wang, J., Liu, Y., Teesalu, T., Sugahara, K.N., Kotamrajua, V.R., Adams, J.D., Ferguson, B.S., Gong, Q., Oh, S.S., Csordas, A.T., Cho, M., Ruoslahti, E., Xiao, Y., Soh, H.T., Selection of phage-displayed peptides on live adherent cells in microfluidic channels. Proc. Natl. Acad. Sci. U.S.A. 108 (2011), 6909–6914.
14. [14] Teesalu, T., Sugahara, K.N., Ruoslahti, E., Tumor-penetrating peptides. Front. Oncol., 3, 2013, 216.
15. [15] Hsiung, P.L., Hardy, J., Friedland, S., Soetikno, R., Du, C.B., Wu, A.P., Sahbaie, P., Crawford, J.M., Lowe, A.W., Contag, C.H., Wang, T.D., Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. Nat. Med. 14 (2008), 454–458.
16. [16] Seigneuric, R., Gobbo, J., Colas, P., Garrido, C., Targeting cancer with peptide aptamers. Oncotarget 2 (2011), 557–561.
17. [17] Hahn, M.A., Singh, A.K., Sharma, P., Brown, S.C., Moudgil, B.M., Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives. Anal. Bioanal. Chem. 399 (2011), 3–27.
18. [18] Thakor, A.S., Jokerst, J., Zavaleta, C., Massoud, T.F., Gambhir, S.S., Gold nanoparticles: a revival in precious metal administration to patients. Nano Lett. 11 (2011), 4029–4036.
19. [19] Dubertret, B., Calame, M., Libchaber, A.J., Single-mismatch detection using gold-quenched fluorescent oligonucleotides. Nat. Biotechnol. 19 (2001), 365–370.
20. [20] Saha, K., Agasti, S.S., Kim, C., Li, X., Rotello, V.M., Gold nanoparticles in chemical and biological sensing. Chem. Rev. 112 (2012), 2739–2779.
21. [21] Wang, J., Achilefu, S., Nantz, M., Kang, K.A., Gold nanoparticle-fluorophore complex for conditionally fluorescing signal mediator. Anal. Chim. Acta 695 (2011), 96–104.
22. [22] MacEwan, S.R., Callahan, D.J., Chilkoti, A., Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery. Nanomedicine 5 (2010), 793–806.
23. [23] Singh, N., Karambelkar, A., Gu, L., Lin, K., Miller, J.S., Chen, C.S., Sailor, M.J., Bhatia, S.N., Bioresponsive mesoporous silica nanoparticles for triggered drug release. J. Am. Chem. Soc. 133 (2011), 19582–19585.
24. [24] Su, J., Chen, F., Cryns, V.L., Messersmith, P.B., Catechol polymers for pH-responsive, targeted drug delivery to cancer cells. J. Am. Chem. Soc. 133 (2011), 11850–11853.
25. [25] Sun, P., Zhou, D., Gan, Z., Novel reduction-sensitive micelles for triggered intracellular drug release. J. Control. Release 155 (2011), 96–103.
26. [26] Chakravarthi, S., Jessop, C.E., Bulleid, N.J., The role of glutathione in disulphide bond formation and endoplasmic-reticulum-generated oxidative stress. EMBO Rep. 7 (2006), 271–275.
27. [27] Estrela, J.M., Ortega, A., Obrador, E., Glutathione in cancer biology and therapy. Crit. Rev. Clin. Lab. Sci. 43 (2006), 143–181.
28. [28] Li, L., Nurunnabi, Nafiujjaman, Lee, Y.K., Huh, K.M., GSH-mediated photoactivity of pheophorbide a-conjugated heparin/gold nanoparticle for photodynamic therapy. J. Control. Release 171 (2013), 241–250.
29. [29] Wang, Q.L., Wang, S.R., Ding, Y., Peng, K.J., Lin, X., Qiao, X.R., Liu, Y.L., Wu, C.H., Age-related changes of the redox state of glutathione in plasma. Chin. Med. J. 118 (2005), 1560–1563.
30. [30] Gamcsik, M.P., Kasibhatla, M.S., Teeter, S.D., Colvin, O.M., Glutathione levels in human tumors. Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals 17 (2012), 671–691.
31. [31] Akella, S., Mitra, C.K., Electrochemical studies of glucose oxidase immobilized on glutathione coated gold nanoparticles. Indian J. Biochem. Biophys. 44 (2007), 82–87.
32. [32] Luo, G.F., Chen, W.H., Liu, Y., Lei, Q., Zhuo, R.X., Zhang, X.Z., Multifunctional enveloped mesoporous silica nanoparticles for subcellular co-delivery of drug and therapeutic peptide. Sci. Rep., 4, 2014, 6064.
33. [33] Cho, D.Y., Lin, S.Z., Yang, W.K., Lee, H.C., Hsu, D.M., Lin, H.L., Chen, C.C., Liu, C.L., Lee, W.Y., Ho, L.H., Targeting cancer stem cells for treatment of glioblastoma multiforme. Cell Transplant. 22 (2013), 731–739.
34. [34] Oka, N., Soeda, A., Inagaki, A., Onodera, M., Maruyama, H., Hara, A., Kunisada, T., Mori, H., Iwana, T., VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells. Biochem. Biophys. Res. Commun. 360 (2007), 553–559.
35. [35] Kumar, D., Meenan, B.J., Dixon, D., Glutathione-mediated release of Bodipy(R) from PEG cofunctionalized gold nanoparticles. Int. J. Nanomed. 7 (2012), 4007–4022.
36. [36] Inagaki, A., Soeda, A., Oka, N., Kitajima, H., Nakagawa, J., Motohashi, T., Kunisada, T., Iwama, T., Long-term maintenance of brain tumor stem cell properties under at non-adherent and adherent culture conditions. Biochem. Biophys. Res. Commun. 361 (2007), 586–592.
37. [37] Heuser, J.E., Anderson, R.G., Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J. Cell Biol. 108 (1989), 389–400.
38. [38] Chen, C.L., Hou, W.H., Liu, I.H., Hsiao, G., Huang, S.S., Huang, J.S., Inhibitors of clathrin-dependent endocytosis enhance TGFbeta signaling and responses. J. Cell Sci. 122 (2009), 1863–1871.
39. [39] Sato, K., Hosokawa, K., Maeda, M., Non-cross-linking gold nanoparticle aggregation as a detection method for single-base substitutions. Nucleic Acids Res., 33, 2005, e4.
40. [40] He, H., Xie, C., Ren, J., Nonbleaching fluorescence of gold nanoparticles and its applications in cancer cell imaging. Anal. Chem. 80 (2008), 5951–5957.
41. [41] Chen, Y.W., Liou, G.G., Pan, H.B., Tseng, H.H., Hung, Y.T., Chou, C.P., Specific detection of CD133-positive tumor cells with iron oxide nanoparticles labeling using noninvasive molecular magnetic resonance imaging. Int. J. Nanomed. 10 (2015), 6997–7018.
42. [42] Lowe, D., Dudgeon, K., Rouet, R., Schofield, P., Jermutus, L., Christ, D., Aggregation, stability, and formulation of human antibody therapeutics. Adv. Protein Chem. Struct. Biol. 84 (2011), 41–61.
43. [43] Iacopino, F., Angelucci, C., Piacentini, R., Biamonte, F., Mangiola, A., Maira, G., Grassi, C., Sica, G., Isolation of cancer stem cells from three human glioblastoma cell lines: characterization of two selected clones. PLoS One, 9, 2014, e105166.
44. [44] Bourseau-Guilmain, E., Griveau, A., Benoit, J.P., Garcion, E., The importance of the stem cell marker prominin-1/CD133 in the uptake of transferrin and in iron metabolism in human colon cancer Caco-2 cells. PLoS One, 6, 2011, e25515.
45. [45] Vercauteren, D., Vandenbroucke, R.E., Jones, A.T., Rejman, J., Demeester, J., De Smedt, S.C., Sanders, N.N., Braeckmans, K., The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls. Mol. Ther. 18 (2010), 561–569.
46. [46] Oishi, M., Tamura, A., Nakamura, T., Nagasaki, Y., A smart nanoprobe based on fluorescence-quenching PEGylated nanogels containing gold nanoparticles for monitoring the response to cancer therapy. Adv. Funct. Mater. 19 (2009), 827–834.
47. [47] Scherf, T., Kasher, R., Balass, M., Fridkin, M., Fuchs, S., Katchalski-Katzir, E., A beta-hairpin structure in a 13-mer peptide that binds alpha-bungarotoxin with high affinity and neutralizes its toxicity. Proc. Natl. Acad. Sci. U.S.A. 98 (2001), 6629–6634.
48. [48] Deponte, M., Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes. Biochim. Biophys. Acta 1830 (2013), 3217–3266.
49. [49] Kato, Y., Ozawa, S., Miyamoto, C., Maehata, Y., Suzuki, A., Maeda, T., Baba, Y., Acidic extracellular microenvironment and cancer. Cancer Cell Int., 13, 2013, 89.
50. [50] Lim, S., Kim, W.J., Kim, Y.H., Lee, S., Koo, J.H., Lee, J.A., Yoon, H., Kim, D.H., Park, H.J., Kim, H.M., Lee, H.G., Yun Kim, J., Lee, J.U., Hun Shin, J., Kyun Kim, L., Doh, J., Kim, H., Lee, S.K., Bothwell, A.L., Suh, M., Choi, J.M., DNP2 is a blood-brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis. Nat. Commun., 6, 2015.
51. [51] Dhuria, S.V., Hanson, L.R., Frey, W.H. 2nd, Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J. Pharm. Sci. 99 (2010), 1654–1673.
52. [52] Thorne, R.G., Nicholson, C., In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space. Proc. Natl. Acad. Sci. U.S.A. 103 (2006), 5567–5572.